Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Subscribe To Our Newsletter & Stay Updated